TRAC

TRAC Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (2)
Etikett
His Tag (1)Fc Tag (1)
Marker
Unconjugated (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
TRC-H5257	Human	HEK293	Human TRAC Protein, Fc Tag				In den Warenkorb legen
TRC-H52H3	Human	HEK293	Human TRAC Protein, His Tag				In den Warenkorb legen

Gesamtmenge2

TRAC Molekülhintergrund

The transmembrane protein, TCR, comprise of two disulphide-linked polypeptide chains: a α and β chain, a γ and δ chain. Each polypeptide chain consists of a variable and a constant region. TRAC is the constant region of T-cell receptor (TCR) alpha chain. TRAC is presented on the surface of T cell and recognized peptide-major histocompatibility (MH) (pMH) that are displayed by antigen presenting cells (APC). TRAC is participate in adaptive immune response and has been well-studied in T cell therapy.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
MT-2765	MT-2765	Phase 3 Clinical	Mitsubishi Tanabe Pharma Corp	Hypertension	Details
SP-20104 (Sarfez Pharmaceuticals)	SP-20104	Phase 2 Clinical	1 A Pharma Gmbh	Glomerulosclerosis, Focal Segmental	Details
Imarikiren hydrochloride	TAK-272; SCO-272	Phase 2 Clinical	Takeda Pharmaceutical Co Ltd	Kidney Diseases; Hypertension; Diabetic Nephropathies; Hepatic Insufficiency	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Aliskiren Hemifumarate/Amlodipine Besilate/Hydrochlorothiazide		Approved	Novartis Pharma Ag	Rasitrio, Amturnide	United States	Hypertension	null	2010-12-21	Hypertension; Essential Hypertension	Details
Aliskiren Hemifumarate	SPP-100; SPP-100A; SPP-100B; CGP-60536; CGP-60536B	Approved	Novartis Pharma Ag	Enviage, Rasilez, Riprazo, Sprimeo, Tekturna, 锐思力	United States	Hypertension	Noden Pharma Dac	2007-03-05	Myocardial Ischemia; Heart Failure; Myocardial Infarction; Diabetes Mellitus, Type 2; Glomerulonephritis, IGA; Coronary Artery Disease; Hypertension; Hypertrophy, Left Ventricular; Diabetic macular oedema; Cardiovascular Diseases; Diabetic Nephropathies; Essential Hypertension; Overweight; Diabetes Mellitus; Kidney Failure, Chronic	Details
Aliskiren		Approved			Mainland China	Essential Hypertension	Novartis Pharma Ag	2010-03-26	Essential Hypertension	Details